Related Experiment Video
Updated: Jun 10, 2026

Visualisation and Quantification of Intracellular Interactions of Neisseria meningitidis and Human α-actinin by Confocal Imaging
Published on: October 24, 2010
Factor H binding protein (FHbp): An evaluation of genotypic diversity across Neisseria meningitidis serogroups
Zhenghui Li1, Ashlesh Krishna Murthy1, Li Hao1
1Pfizer Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Abstract:
Neisseria meningitidis serogroups A, B, C, W, X, and Y cause invasive meningococcal disease (IMD) worldwide. Factor H binding protein (FHbp), a key meningococcal virulence factor, is an antigen included in both licensed meningococcal serogroup B (MenB) vaccines. This review examines the biology and epidemiology of FHbp and assesses the ability and potential of FHbp vaccine antigens to protect against IMD. Using evidence from the literature and the contemporary PubMLST database, we discuss analyses of MenB genotypes on the representation of the most prevalent multilocus sequence typing (MLST)/clonal complexes, FHbp subfamily distribution, and FHbp and porin A (PorA) variants. We further discuss that the similar genotypes, distribution, and diversity of FHbp variant types have remained stable over long time periods, supporting the potential for FHbp-containing, protein-based vaccines to protect against IMD, including MenB-FHbp (Trumenba®), which contains two lipidated FHbp antigens (one each from both FHbp subfamilies: A and B).
Insights
Factor H binding protein (FHbp) is a key virulence factor in invasive meningococcal disease (IMD). FHbp-based vaccines show potential for broad protection against IMD, including MenB disease.
Area of Science:
- Microbiology
- Vaccinology
- Epidemiology
Background:
- Invasive meningococcal disease (IMD) is caused by *Neisseria meningitidis* serogroups A, B, C, W, X, and Y.
- Factor H binding protein (FHbp) is a critical meningococcal virulence factor and an antigen in licensed serogroup B (MenB) vaccines.
Purpose of the Study:
- To review the biology and epidemiology of FHbp.
- To assess the protective potential of FHbp vaccine antigens against IMD.
Main Methods:
- Literature review and analysis of the PubMLST database.
- Examination of MenB genotypes, multilocus sequence typing (MLST)/clonal complexes, FHbp subfamilies, and FHbp/PorA variants.
Main Results:
- FHbp subfamily distribution and variant types show stable genotypes, distribution, and diversity over time.
- Analyses included prevalent MLST/clonal complexes and FHbp/PorA variants.
Conclusions:
- The stability of FHbp variant types supports the potential of FHbp-containing protein-based vaccines for IMD protection.
- MenB-FHbp (Trumenba®) utilizes FHbp antigens from subfamilies A and B for protection.
Related Concept Videos
Fimbriae, Pili, and Axial Filaments
Bacterial Meningitis II: Pathophysiology

